BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gille T, Laveneziana P. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency. Eur Respir Rev 2021;30:200355. [PMID: 34853093 DOI: 10.1183/16000617.0355-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Waxman AB, Elia D, Adir Y, Humbert M, Harari S. Recent advances in the management of pulmonary hypertension with interstitial lung disease. Eur Respir Rev 2022;31:210220. [PMID: 35831007 DOI: 10.1183/16000617.0220-2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Noureddine S, Roux-claudé P, Laurent L, Ritter O, Dolla P, Karaer S, Claudé F, Eberst G, Westeel V, Barnig C. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for critical COVID-19.. [DOI: 10.1101/2022.09.12.22279779] [Reference Citation Analysis]
3 Banydeen R, Monfort A, Inamo J, Neviere R. Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis. Front Cardiovasc Med 2022;9:898033. [DOI: 10.3389/fcvm.2022.898033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]